Patent · US Active

RAAV-based compositions and methods

US11254939B2 · kind B2 · utility

1Cited by

31References

20Claims

0Family size

Assignee

University of Massachusetts · US

Inventors

Terence Flotte · Holden, US
Christian Mueller · Wiesbaden, DE
Phillip D. Zamore · Marlborough, US

Key dates

Filing date	Feb 20, 2020
Grant date	Feb 22, 2022
Priority date	—
Expiry date	Feb 20, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.